METHOD OF PROVIDING ARIPIPRAZOLE TO PATIENTS HAVING IMPAIRED CYP2D6 OR CYP3A4 ENZYME FUNCTION
- 专利权人:
- Otsuka Pharmaceutical Co.; Ltd.
- 发明人:
- Arash Raoufinia
- 申请号：
- US14034727
- 公开号：
- US20150087654A1
- 申请日:
- 2013.09.24
- 申请国别(地区):
- US
- 年份:
- 2015
- 代理人:
- 摘要：
- The disclosed embodiments relate to methods of initiating aripiprazole treatment in a patient who is a CYP2D6 poor metabolizer or a CYP3A4 poor metabolizer, or both.
- 来源网站：
- 中国工程科技知识中心
